Molecular and immunologic approaches in the management of bladder cancerFRADET, Y.Urologic clinics of North America. 1991, Vol 18, Num 3, pp 515-524, issn 0094-0143Article

Markers of prognosis in superficial bladder cancerFRADET, Y.Seminars in urology. 1992, Vol 10, Num 1, pp 28-38, issn 0730-9147Article

INFLUENCE OF HLA-A AND HLA-B CROSS-REACTIVE ANTIGEN MATCHING ON KIDNEY GRAFT SURVIVALROY R; FRADET Y; LACHANCE JG et al.1981; TISSUE ANTIGENS; ISSN 0001-2815; DNK; DA. 1981; VOL. 18; NO 2; PP. 101-104; BIBL. 10 REF.Article

IMMUNOLOGICAL ACTIVITIES OF RAT LYMPHOCYTES. II. ISOLATION OF SUPPRESSOR CELLS OF THE MITOGENIC RESPONSE OF RAT THORACIC DUCT LYMPHOCYTESTARDIEU M; FRADET Y; DAGUILLARD F et al.1975; CELL. IMMUNOL.; U.S.A.; DA. 1975; VOL. 17; NO 1; PP. 123-130; BIBL. 17REF.Article

ACTIVITES IMMUNOLOGIQUES DES LYMPHOCYTES DE RATS. IV. VARIATION FONCTIONNELLE CHRONOLOGIQUE DES LYMPHOCYTES DU CANAL THORACIQUE.FRADET Y; MCNICOLL J; DAGUILLARD F et al.1977; UN. MED. CANADA; CANADA; DA. 1977; VOL. 106; NO 7; PP. 951-955; ABS. ANGL.; BIBL. 19 REF.Article

REGULATION OF IN VITRO LYMPHOCYTE RESPONSES. I. ADJUVANT EFFECT OF LIPOPOLYSACCHARIDE (LPS) ON LOW-ZONE UNRESPONSIVENESS TO CONCANAVALIN A.FRADET Y; ROY R; DAGUILLARD F et al.1976; CELL. IMMUNOL.; U.S.A.; DA. 1976; VOL. 27; NO 1; PP. 94-101; BIBL. 35 REF.Article

KIDNEY GRAFT SURVIVAL: ROLE OF BLOOD TRANSFUSIONS AND LYMPHOCYTOTOXIC ANTIBODIESFRADET Y; ROY R; LACHANCE JG et al.1982; CLIN. NEPHROL.; ISSN 0301-0430; DEU; DA. 1982; VOL. 18; NO 2; PP. 69-73; BIBL. 19 REF.Article

ENHANCED URINARY PROSTAGLANDIN E₂ IN POSTOBSTRUCTIVE DIURESIS IN HUMANSFRADET Y; SIMARD J; GROSE JH et al.1980; PROSTAGLANDINS MED.; GBR; DA. 1980; VOL. 5; NO 1; PP. 29-30; BIBL. 6 REF.Article

ETUDE DE CERTAINES PROPRIETES DU LYMPHOCYTE T INHIBITEUR.DAGUILLARD F; TARDIEU M; FRADET Y et al.1976; REV. MED.; FR.; DA. 1976; VOL. 17; NO 32; PP. 1691-1692; ABS. ANGL.; BIBL. 15 REF.Article

Growth-regulated surface glycoproteins of human bladder cancerGAUTHIER, J; FRADET, Y.Cancer research (Baltimore). 1990, Vol 50, Num 2, pp 293-298, issn 0008-5472Article

CHARACTERIZATION OF LYMPHOCYTOTOXIC ANTIBODIES IN RENAL TRANSPLANTATIONROY R; LACHANCE JG; FRADET Y et al.1981; TRANSPLANTATION; ISSN 0041-1337; USA; DA. 1981; VOL. 31; NO 1; PP. 31-33; BIBL. 17 REF.Article

Critical appraisal of tumor markers in bladder cancerFRADET, Y; CORDON-CARDO, C.Seminars in urology. 1993, Vol 11, Num 3, pp 145-153, issn 0730-9147Article

Identification of a superficial bladder tumor-associated glycoform of the carcinoembryonic antigen by monoclonal antibody 19A211BERGERON, A; LARUE, H; FRADET, Y et al.Cancer research (Baltimore). 1996, Vol 56, Num 4, pp 908-915, issn 0008-5472Article

Human papillomavirus in transitional cell carcinoma of the urinary bladderLARUE, H; SIMONEAU, M; FRADET, Y et al.Clinical cancer research. 1995, Vol 1, Num 4, pp 435-440, issn 1078-0432Article

Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodiesFRADET, Y; TARDIF, M; BOURGET, L et al.Cancer research (Baltimore). 1990, Vol 50, Num 2, pp 432-437, issn 0008-5472Article

Le traitement du cancer localisé de la prostate par implantation d'iode radioactif = Treatment of prostatic carcinoma with implant of radioactive iodineFRADET, Y; LAVERDIERE, J; BEAUDOIN, L et al.Union médicale du Canada. 1985, Vol 114, Num 9, pp 737-739, issn 0041-6959Article

Phenotypic characterization of bladder cancerFRADET, Y.European urology. 1998, Vol 33, pp 5-6, issn 0302-2838, SUP4Conference Paper

The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic indexALLARD, P; BERNARD, P; FRADET, Y et al.British journal of urology (Print). 1998, Vol 81, Num 5, pp 692-698, issn 0007-1331Article

Dietary energy and nutrients in relation to preclinical prostate cancerMEYER, F; BAIRATI, I; FRADET, Y et al.Nutrition and cancer. 1997, Vol 29, Num 2, pp 120-126, issn 0163-5581Article

Dietary fat and advanced prostate cancerBAIRATI, I; MEYER, F; FRADET, Y et al.The Journal of urology. 1998, Vol 159, Num 4, pp 1271-1275, issn 0022-5347Article

Intérêt clinique de l'étude d'antigènes de prolifération et d'activation cellulaire par cytométrie en flux dans le cancer de la vessie = Clinical interest of the study of proliferation and cell activation antigens by multiparametric flow cytometry in bladder cancerLACOMBE, L; GAUTHIER, J; LAFLEUR, L et al.Progrès en urologie (Paris). 1996, Vol 6, Num 6, pp 907-912, issn 1166-7087Article

The role of neoadjuvant androgen deprivation prior to radical prostatectomyFRADET, Y.Urologic clinics of North America. 1996, Vol 23, Num 4, issn 0094-0143, viii, 575-585 [12 p.]Article

Apport de la fluxcytométrie à paramètres multiples à la détection et à l'évaluation des tumeurs vésicales humaines = Detection and evaluation of vesical tumor in humans by flowcytometryFRADET, Y; TARDIF, M; PARENT-VAUGEOIS, C et al.Union médicale du Canada. 1985, Vol 114, Num 9, pp 778-780, issn 0041-6959Article

CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy : 36-month post-treatment PSA resultsKLOTZ, L. H; GOLDENBERG, S. L; JEWETT, M et al.Urology (Ridgewood, NJ). 1999, Vol 53, Num 4, pp 757-763, issn 0090-4295Article

Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgeryJEWETT, M. A. S; VALIQUETTE, L; SAMPSON, H. A et al.The Journal of urology. 1999, Vol 161, Num 2, pp 482-485, issn 0022-5347Article